Treatment of kidney disease with angiopoietin-like 3 (ANGPTL3) inhibitors

The present disclosure provides methods of treating a subject having or at risk of developing a kidney disease by administering an Angiopoietin-like 3 (ANGPTL3) inhibitor, and methods of identifying a subject having an increased risk of developing a kidney disease. 本公开提供了通过施用血管生成素样3(ANGPTL3)抑制剂来治疗患有...

Full description

Saved in:
Bibliographic Details
Main Authors SUN LUANLUAN, FERREIRA MARCOS ANTONIO ROCHA, HAAS, MICHAEL, E, BALLAS, ASSAF, DEVALARAJA NARASIMHA KARTHIK, MORTON LISA, LOTTA, LOUIS, A
Format Patent
LanguageChinese
English
Published 09.08.2024
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present disclosure provides methods of treating a subject having or at risk of developing a kidney disease by administering an Angiopoietin-like 3 (ANGPTL3) inhibitor, and methods of identifying a subject having an increased risk of developing a kidney disease. 本公开提供了通过施用血管生成素样3(ANGPTL3)抑制剂来治疗患有肾脏疾病或处于发展成肾脏疾病的风险的受试者的方法，以及鉴定发展成肾脏疾病的风险增加的受试者的方法。
Bibliography:Application Number: CN20228085488